ORBIMED ADVISORS LLC Insider Trading $XTNT Xtant Medical Holdings, Inc.
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
ORBIMED ADVISORS LLC in Xtant Medical Holdings, Inc.
Trading Symbol: XTNTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 53,468,376 shares
Current Value: $24,060,769
Latest Transaction: Nov 19 2020
$XTNT Market Capitalization: $5.29M
$XTNT Previous Close: $0.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Xtant Medical Holdings, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 868,016 | 8,680 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 1,531,984 | 15,320 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 868,016 | 8,680 | 17,036,720 | 16.2 M to 17 M (+5.37 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 434,008 | 4,340 | 16,168,704 | 15.7 M to 16.2 M (+2.76 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 434,008 | 4,340 | 15,734,696 | 15.3 M to 15.7 M (+2.84 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 1,531,984 | 15,320 | 55,766,352 | 54.2 M to 55.8 M (+2.82 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 765,992 | 7,660 | 54,234,368 | 53.5 M to 54.2 M (+1.43 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 765,992 | 7,660 | 53,468,376 | 52.7 M to 53.5 M (+1.45 %) |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 868,016 | 8,680 | 868,016 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 1,531,984 | 15,320 | 1,531,984 | |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 809,614 | 28,174,567 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 1,428,553 | 49,713,644 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 18,810,000 | 875,793,600 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 33,190,000 | 1,545,326,400 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 342,132 | 2,463,350 | 3,316,128 | 3 M to 3.3 M (+11.50 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 603,687 | 4,346,546 | 5,890,884 | 5.3 M to 5.9 M (+11.42 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 2,905,396 | 20,918,851 | 2,973,996 | 68.6 K to 3 M (+4,235.27 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 5,126,534 | 36,911,045 | 5,287,197 | 160.7 K to 5.3 M (+3,190.86 %) |
Page: 1